KRIZIA ROBLEDO: Open Payments
NPI 1033656491 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 20 payments from 13 companies in 2025. Trend: 2023 $971 · 2024 $854 · 2025 $1,208
Food & beverage: $1,208
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $252 |
| Janssen Pharmaceuticals, Inc | 2 | $222 |
| Teva Pharmaceuticals USA, Inc. | 4 | $177 |
| Teleflex LLC | 1 | $146 |
| Novo Nordisk Inc | 2 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| PFIZER INC. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: SPRAVATO, AUSTEDO XR, UROLIFT, BREZTRI, AIRSUPRA, Ozempic, CAPLYTA, REXULTI.
Industry payments across LA — which companies pay providers there.
